Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB-PVVR Cause Incorrect dose administered? 44 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Incorrect dose administered have been filed in association with RITUXIMAB-PVVR. This represents 1.1% of all adverse event reports for RITUXIMAB-PVVR.

44
Reports of Incorrect dose administered with RITUXIMAB-PVVR
1.1%
of all RITUXIMAB-PVVR reports
4
Deaths
12
Hospitalizations

How Dangerous Is Incorrect dose administered From RITUXIMAB-PVVR?

Of the 44 reports, 4 (9.1%) resulted in death, 12 (27.3%) required hospitalization, and 1 (2.3%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-PVVR. However, 44 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB-PVVR Cause?

Off label use (2,079) Intentional product use issue (627) Condition aggravated (514) Death (338) Covid-19 (322) Fatigue (318) Dyspnoea (314) Inappropriate schedule of product administration (311) Headache (291) Pruritus (288)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which RITUXIMAB-PVVR Alternatives Have Lower Incorrect dose administered Risk?

RITUXIMAB-PVVR vs RIVAROXABAN RITUXIMAB-PVVR vs RIVASTIGMINE RITUXIMAB-PVVR vs RIVOTRIL RITUXIMAB-PVVR vs RIZATRIPTAN RITUXIMAB-PVVR vs ROACTEMRA

Related Pages

RITUXIMAB-PVVR Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered RITUXIMAB-PVVR Demographics